With two COVID-19 vaccines now in the final stages of approval for use in the U.S., 63% of Americans say they are willing to be immunized against the disease. The public’s willingness to receive a COVID-19 vaccination approved by the Food and Drug Administration (FDA) has nearly rebounded to the previous high of 66% after hitting a 50% low point in September.
These latest findings are from the probability-based online Gallup Panel survey conducted Nov. 16-29, which began a week after the announcement by Pfizer and BioNTech that their COVID-19 vaccine had proved better than 90% effective in Phase 3 clinical trials. Since then, Moderna has made a similar announcement, and both companies have applied for emergency use authorization from the FDA for their vaccines. The FDA will hold hearings in the coming weeks to decide whether to grant authorization to both companies. If approved, some Americans could begin to receive vaccines before the end of the year.